SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-277143
Filing Date
2023-11-14
Accepted
2023-11-14 16:31:13
Documents
70
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d569965d10q.htm   iXBRL 10-Q 946411
2 EX-10.1 d569965dex101.htm EX-10.1 100732
3 EX-31.1 d569965dex311.htm EX-31.1 10097
4 EX-31.2 d569965dex312.htm EX-31.2 10096
5 EX-32.1 d569965dex321.htm EX-32.1 4039
6 EX-32.2 d569965dex322.htm EX-32.2 4041
  Complete submission text file 0001193125-23-277143.txt   5943976

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA txmd-20230930.xsd EX-101.SCH 55496
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE txmd-20230930_cal.xml EX-101.CAL 58156
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE txmd-20230930_def.xml EX-101.DEF 247544
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20230930_lab.xml EX-101.LAB 424452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20230930_pre.xml EX-101.PRE 367789
64 EXTRACTED XBRL INSTANCE DOCUMENT d569965d10q_htm.xml XML 850132
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 231407029
SIC: 2834 Pharmaceutical Preparations